Treatment
Oral medications
Oral medications are sometimes part of a Peyronie's plan, but the evidence is limited. They are rarely the plan on their own.
Oral options have been studied for decades, often with disappointing or mixed results. Most have not shown consistent benefit on curvature, plaque, or function in well-controlled studies.
Where oral medications can earn a place is alongside other care: for symptom relief, vascular support, or as part of a broader plan that addresses ED or co-existing conditions.
What to know about oral medications
Limited evidence for shape correction
Most oral options have not changed curvature reliably in well-designed trials. Honest care does not present them as primary structural treatments.
Some role in active-phase symptom support
Anti-inflammatories and similar agents are sometimes used short-term for pain or discomfort during the active phase.
ED medications are a different conversation
Drugs for erectile function (PDE5 inhibitors) are not Peyronie's treatments per se, but they are common when ED overlaps with Peyronie's.
Side effects and interactions matter
Even modest-benefit drugs need a clear risk conversation. Other medications, vascular health, and age all factor in.
Be cautious about strong claims
Supplements and oral combinations marketed for Peyronie's often outpace their evidence. Ask what trial supports the specific claim.
If a clinician suggests an oral medication, ask what outcome is expected, on what timeline, and whether the evidence supports that specific use, or whether it is supportive care rather than a structural treatment.
Treat oral medications as one part of a plan, not the whole plan, and ask what the evidence actually supports.
Stay informed
Get practical Peyronie's updates
Receive new guides, treatment explainers, and evidence-based updates by email. Unsubscribe at any time.